Screening strategy to advance HCV elimination in Italy: a cost-consequence analysis.
Andrea MarcellusiFrancesco Saverio MenniniMassimo AndreoniLoreta A Kondilinull nullPublished in: The European journal of health economics : HEPAC : health economics in prevention and care (2024)
It is necessary to guarantee dedicated funds and efficiency of the system for the cost-efficacious screening of the 1948-1968 birth cohort in Italy. A delay in HCV diagnosis and treatment in the general population, yet not addressed for the HCV free-of-charge screening, will have important clinical and economic consequences in Italy.